Anglo Nordic Life Science

At the 19th Annual Anglonordic Life Science Conference, over 300 delegates:

MET decision makers at leading and upcoming drug discovery and technology companies from the UK and Nordic regions, and investment firms throughout Europe.

LEARNED from major investment firms about the current status of European investment in life science technologies.

GAINED insights from experienced life science operators within the Anglo-Nordic space.

Anglonordic has a 20-year tradition as an invitation-only gathering of investors and R&D growth companies that consistently offers unique opportunities for funding and collaboration.